Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 341, pseudogene (RN7SL341P) is a processed pseudogene located in the human genome and belongs to the 7SL RNA family. While the functional 7SL RNA forms the essential RNA component of the signal recognition particle (SRP), which mediates the co-translational insertion of secretory and membrane proteins, RN7SL pseudogenes such as RN7SL341P are non-functional genetic elements. Most 7SL-related sequences in the human genome are truncated, non-expressed, and arise from reverse transcription of 7SL RNA and integration into new genomic sites. There is no evidence for RN7SL341P expression or function, and it is not considered a receptor, enzyme, or other conventional therapeutic target[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 341, pseudogene (RN7SL341P).